Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease

References

• DuttaRTrappBDPathogenesis of axonal and neuronal damage in multiple sclerosisNeurology20076822 Suppl 3S22S31 discussion S43–S5417548565
   PubMed Web of Science ®Google Scholar
• PetersonJWTrappBDNeuropathobiology of multiple sclerosisNeurol Clin2005231107129vivii15661090
   PubMed Web of Science ®Google Scholar
• NoseworthyJLucchinettiCRodgriguezMWeinshenkerBMultiple sclerosisN Engl J Med20003431393895211006371
   PubMed Web of Science ®Google Scholar
• LassmannHBruckWLucchinettiCFThe immunopathology of multiple sclerosis: an overviewBrain Pathol200717221021817388952
   PubMed Web of Science ®Google Scholar
• FilippiMRovarisMRoccaMAImaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques. Mult SclerJun200410Suppl 1S36S44 discussion S44–S45
   Google Scholar
• BarkhofFCalabresiPAMillerDHReingoldSCImaging outcomes for neuroprotection and repair in multiple sclerosis trialsNat Rev Neurol20095525626619488083
   PubMed Web of Science ®Google Scholar
• DeLucaGCRamagopalanSVCaderMZThe role of hereditary spastic paraplegia related genes in multiple sclerosis. A study of disease susceptibility and clinical outcomeJ Neurol200725491221122617420921
   PubMed Web of Science ®Google Scholar
• SoldanSBertiRSalemNAssociation of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNANat Med1997312139413979396611
   PubMed Web of Science ®Google Scholar
• SriramSStrattonCYaoSChlamydia pneumonaie infection of the central nervous system in multiple sclerosisAnn Neurol199946161410401775
   PubMed Web of Science ®Google Scholar
• ThackerELMirzaeiFAscherioAInfectious mononucleosis and risk for multiple sclerosis: a meta-analysisAnn Neurol200659349950316502434
   PubMed Web of Science ®Google Scholar
• LeeSXuLShinYA potential link between autoimmunity and neurodegeneration in immune-mediated neurological diseaseJ Neuroimmunol20112351–2566921570130
   PubMed Web of Science ®Google Scholar
• LeeSLevinMCMolecular mimicry in neurological disease: what is the evidence?Cell Mol Life Sci2008657–81161117518193392
   PubMed Web of Science ®Google Scholar
• LeeSMMorocosYJangHStuartJMLevinMCHTLV-1 induced molecular mimicry in neurologic diseaseOldstoneMMolecular Mimicry: Infection Inducing Autoimmune DiseaseNew YorkSpringer2005
   Google Scholar
• LevinMCLeeSMKalumeFAutoimmunity due to molecular mimicry as a cause of neurological disease. Nat MedMay200285509513
   Google Scholar
• WucherpfennigKWInfectious triggers for inflammatory neurological diseasesNat Med20028545545711984586
   PubMed Web of Science ®Google Scholar
• PoeiszBRuscettiFGazdarABunnPMinnaJGalloRDetection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphomaProc Natl Acad Sci19807712741574196261256
   PubMed Web of Science ®Google Scholar
• GessainAVernantJMaursLAntibodies to human T-lymphotropic virus I in patients with tropical spastic paraparesisLancet198524074102863442
   PubMed Web of Science ®Google Scholar
• OsameMUsukuKIzumoSHTLV-I associated myelopathy, a new clinical entityLancet19861848810311032
   PubMed Web of Science ®Google Scholar
• LevinMLehkyTFlerlageNImmunopathogenesis of HTLV-1 associated neurologic disease based on a spinal cord biopsy from a patient with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)N Engl J Med19973368398459062093
   PubMed Web of Science ®Google Scholar
• LevinMCJacobsonSHTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous systemJ Neurovirol1997321261409111175
   PubMed Web of Science ®Google Scholar
• AraujoAQSilvaMTThe HTLV-1 neurological complexLancet Neurol20065121068107617110288
   PubMed Web of Science ®Google Scholar
• VerdonckKGonzalezEVan DoorenSVandammeAMVanhamGGotuzzoEHuman T-lymphotropic virus 1: recent knowledge about an ancient infectionLancet Infect Dis20077426628117376384
   PubMed Web of Science ®Google Scholar
• JacobsonSThe NK cell as a new player in the pathogenesis of HTLV-I associated neurologic diseaseVirulence2010118921178408
   PubMed Web of Science ®Google Scholar
• MartinFBanghamCRCiminaleVConference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, June 4–8, 2011. Leuven, Gembloux, BelgiumRetrovirology201188622035054
   PubMed Web of Science ®Google Scholar
• Puccioni-SohlerMYamanoYRiosMDifferentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-INeurology200768320621317224575
   PubMed Web of Science ®Google Scholar
• KhanRBBertoriniTELevinMCHTLV-1 and its neurological complicationsNeurologist20017527127812803668
   PubMed Web of Science ®Google Scholar
• SoderblomCBlackstoneCTraffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegiasPharmacol Ther20061091–2425616005518
   PubMed Web of Science ®Google Scholar
• SalinasSProukakisCCrosbyAWarnerTTHereditary spastic paraplegia: clinical features and pathogenetic mechanismsLancet Neurol20087121127113819007737
   PubMed Web of Science ®Google Scholar
• UmeharaFAbeMKoreedaYIzumoSOsameMAxonal damage revealed by accumulation of beta-amyloid precursor protein in HTLV-I-associated myelopathyJ Neurol Sci200017629510110930590
   PubMed Web of Science ®Google Scholar
• JerniganMMorcosYLeeSMDohanFCJrRaineCLevinMCIgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic diseaseNeurology20036081320132712707436
   PubMed Web of Science ®Google Scholar
• DelucaGCEbersGCEsiriMMThe extent of axonal loss in the long tracts in hereditary spastic paraplegiaNeuropathol Appl Neurobiol200430657658415540998
   PubMed Web of Science ®Google Scholar
• DeLucaGCEbersGCEsiriMMAxonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tractsBrain2004127Pt 51009101815047586
   PubMed Web of Science ®Google Scholar
• IzumoSNeuropathology of HTLV-1-associated myelopathy (HAM/TSP)Neuropathology Epub6212010
   Google Scholar
• TrappBDNaveKAMultiple sclerosis: an immune or neurodegenerative disorder?Annu Rev Neurosci20083124726918558855
   PubMed Web of Science ®Google Scholar
• GeurtsJJBarkhofFGrey matter pathology in multiple sclerosisLancet Neurol20087984185118703006
   PubMed Web of Science ®Google Scholar
• KutzelniggALucchinettiCFStadelmannCCortical demyelination and diffuse white matter injury in multiple sclerosisBrain2005128Pt 112705271216230320
   PubMed Web of Science ®Google Scholar
• KornekBStorchMKWeissertRMultiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesionsAm J Pathol2000157126727610880396
   PubMed Web of Science ®Google Scholar
• GoldRLiningtonCLassmannHUnderstanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis researchBrain2006129Pt 81953197116632554
   PubMed Web of Science ®Google Scholar
• Aboul-EneinFWeiserPHoftbergerRLassmannHBradlMTransient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitisActa Neuropathol (Berl)2006111653954716718350
   PubMed Web of Science ®Google Scholar
• LassmannHMultiple sclerosis: is there neurodegeneration independent from inflammation?J Neurol Sci20072591–23617367814
   PubMed Web of Science ®Google Scholar
• BjartmarCWujekJRTrappBDAxonal loss in the pathology of MS: consequences for understanding the progressive phase of the diseaseJ Neurol Sci2003206216517112559505
   PubMed Web of Science ®Google Scholar
• LassmannHvan HorssenJThe molecular basis of neurodegeneration in multiple sclerosisFEBS Lett2011585233715372321854776
   PubMed Web of Science ®Google Scholar
• BennettJLStuveOUpdate on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implicationsClin Neuropharmacol200932312113219483479
   PubMed Web of Science ®Google Scholar
• SteinmanLMixed results with modulation of TH-17 cells in human autoimmune diseasesNat Immunol2010111414420016509
   PubMed Web of Science ®Google Scholar
• McFarlandHFMartinRMultiple sclerosis: a complicated picture of autoimmunityNat Immunol20078991391917712344
   PubMed Web of Science ®Google Scholar
• LisakRPNeurodegeneration in multiple sclerosis: defining the problemNeurology20076822 Suppl 3S5S12 discussion S43–S5417548569
   PubMed Web of Science ®Google Scholar
• FrohmanEMRackeMKRaineCSMultiple sclerosis – the plaque and its pathogenesisN Engl J Med2006354994295516510748
   PubMed Web of Science ®Google Scholar
• FrischerJMBramowSDal-BiancoAThe relation between inflammation and neurodegeneration in multiple sclerosis brains. BrainMay2009132Pt 511751189
   Google Scholar
• TrappBPetersonJRansohoffRRudickRMorkSBoLAxonal transection in the lesions of multiple sclerosisN Engl J Med199833852782859445407
   PubMed Web of Science ®Google Scholar
• LassmannHLucchinettiCFCortical demyelination in CNS inflammatory demyelinating diseasesNeurology200870533233318227414
   PubMed Web of Science ®Google Scholar
• LucchinettiCFPopescuBFBunyanRFInflammatory cortical demyelination in early multiple sclerosisN Engl J Med2011365232188219722150037
   PubMed Web of Science ®Google Scholar
• PetersonJWBoLMorkSChangATrappBDTransected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesionsAnn Neurol200150338940011558796
   PubMed Web of Science ®Google Scholar
• FisherELeeJCNakamuraKRudickRAGray matter atrophy in multiple sclerosis: a longitudinal studyAnn Neurol200864325526518661561
   PubMed Web of Science ®Google Scholar
• FisnikuLKChardDTJacksonJSGray matter atrophy is related to long-term disability in multiple sclerosisAnn Neurol200864324725418570297
   PubMed Web of Science ®Google Scholar
• GeurtsJJIs progressive multiple sclerosis a gray matter disease?Ann Neurol200864323023218825672
   PubMed Web of Science ®Google Scholar
• SerafiniBRosicarelliBMagliozziRStiglianoEAloisiFDetection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosisBrain Pathol200414216417415193029
   PubMed Web of Science ®Google Scholar
• MagliozziRHowellOWReevesCA gradient of neuronal loss and meningeal inflammation in multiple sclerosisAnn Neurol201068447749320976767
   PubMed Web of Science ®Google Scholar
• GanterPPrinceCEsiriMMSpinal cord axonal loss in multiple sclerosis: a post-mortem studyNeuropathol Appl Neurobiol199925645946710632896
   PubMed Web of Science ®Google Scholar
• LovasGSzilagyiNMajtenyiKPalkovitsMKomolySAxonal changes in chronic demyelinated cervical spinal cord plaquesBrain2000123Pt 230831710648438
   PubMed Web of Science ®Google Scholar
• DeLucaGCWilliamsKEvangelouNEbersGCEsiriMMThe contribution of demyelination to axonal loss in multiple sclerosisBrain2006129Pt 61507151616597651
   PubMed Web of Science ®Google Scholar
• EvangelouNDeLucaGCOwensTEsiriMMPathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesionsBrain2005128Pt 1293415548559
   PubMed Web of Science ®Google Scholar
• IzumoSHiguchiIIjichiTNeuropathological study in two autopsy cases of HTLV-1 associated myelopathy (HAM)IwasakiYNeuropathology of HAM/TSP in JapanProceedings of the First Workshop on Neuropathology of Retrovirus InfectionsAugust 31, 1989Tokyo, JapanSendai, JapanTohuku University Press1989717
   Google Scholar
• IzumoSUmeharaFOsameMHTLV-I-associated myelopathyNeuropathology200020SupplS65S6811037191
   PubMed Web of Science ®Google Scholar
• EvangelouIEOhUMassoudRJacobsonSHTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR imagesJ Neuroimaging Epub232012
   Web of Science ®Google Scholar
• FurbyJHaytonTAndersonVMagnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosisMult Scler20081481068107518632782
   PubMed Web of Science ®Google Scholar
• UmeharaFIzumoSNakagawaMImmunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathyJ Neuropathol Exp Neurol19935244244308355031
   PubMed Web of Science ®Google Scholar
• MatsuokaETakenouchiNHashimotoKPerivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridizationActa Neuropathol (Berl)19989643403469796997
   PubMed Web of Science ®Google Scholar
• MoritoyoTReinhartTMoritoyoHHuman T-lymphotropic virus type I associated myelopathy and tax gene expression in CD4+ T lymphocytesAnn Neurol199640184908687197
   PubMed Web of Science ®Google Scholar
• ArayaNSatoTYagishitaNHuman T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory diseaseViruses2011391532154821994794
   PubMed Web of Science ®Google Scholar
• MatsuuraEYamanoYJacobsonSNeuroimmunity of HTLV-I InfectionJ Neuroimmune Pharmacol20105331032520437106
   PubMed Web of Science ®Google Scholar
• TakenouchiNYaoKJacobsonSImmunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approachesFront Biosci200492527253915353305
   PubMed Web of Science ®Google Scholar
• BanghamCROsameMCellular immune response to HTLV-1Oncogene200524396035604616155610
   PubMed Web of Science ®Google Scholar
• BanghamCRMeekingsKToulzaFThe immune control of HTLV-1 infection: selection forces and dynamicsFront Biosci20091428892903
   Web of Science ®Google Scholar
• BanghamCRThe immune response to HTLV-ICurr Opin Immunol200012439740210899027
   PubMed Web of Science ®Google Scholar
• JacobsonSShidaHMcFarlinDEFauciASKoenigSCirculating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological diseaseNature199034862982452482146511
   PubMed Web of Science ®Google Scholar
• LalRBGiamC-ZColiganJERudolphDLDifferential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type 1-associated myelopathyJ Infect Dis199416934965038158021
   PubMed Web of Science ®Google Scholar
• KubotaRFurukawaYIzumoSUsukuKOsameMDegenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP)Blood200310183074308112480698
   PubMed Web of Science ®Google Scholar
• GoonPKHanonEIgakuraTHigh frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesisBlood20029993335334111964301
   PubMed Web of Science ®Google Scholar
• JefferyKJUsukuKHallSEHLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathyProc Natl Acad Sci U S A19999673848385310097126
   PubMed Web of Science ®Google Scholar
• MacnamaraARowanAHilburnSHLA class I binding of HBZ determines outcome in HTLV-1 infectionPLoS Pathog201069e100111720886101
   PubMed Web of Science ®Google Scholar
• SaxenaAMartin-BlondelGMarsLTLiblauRSRole of CD8 T cell subsets in the pathogenesis of multiple sclerosisFEBS Lett2011585233758376321910991
   PubMed Web of Science ®Google Scholar
• SchneiderRMohebianyANIferganIB cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patientsJ Immunol201118784119412821911607
   PubMed Web of Science ®Google Scholar
• YamanoYArayaNSatoTAbnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorderPloS One200948e651719654865
   PubMed Web of Science ®Google Scholar
• NorrisPJHirschkornDFDeVitaDALeeTHMurphyELHuman T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cellsVirulence201011192820640055
   PubMed Web of Science ®Google Scholar
• NagaiMUsukuKMatsumotoWAnalysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly predisposes to HAM/TSPJ Neurovirol19984658659310065900
   PubMed Web of Science ®Google Scholar
• OlindoSLezinACabrePHTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progressionJ Neurol Sci20052371–2535915972218
   PubMed Web of Science ®Google Scholar
• MontanheiroPAOliveiraACPosada-VergaraMPHuman T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesisBraz J Med Biol Res200538111643164716258633
   PubMed Web of Science ®Google Scholar
• TattermuschSSkinnerJAChaussabelDSystems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathyPLoS Pathog201281e100248022291590
   PubMed Web of Science ®Google Scholar
• GoonPKIgakuraTHanonEHigh circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological diseaseJ Virol200377179716972212915584
   PubMed Web of Science ®Google Scholar
• WaxmanSGAxonal conduction and injury in multiple sclerosis: the role of sodium channelsNat Rev Neurosci200671293294117115075
   PubMed Web of Science ®Google Scholar
• DuttaRTrappBMechanisms of neuronal dysfunction and degeneration in multiple sclerosisProg Neurobiol201193111220946934
   PubMed Web of Science ®Google Scholar
• DuttaRMcDonoughJYinXMitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patientsAnn Neurol200659347848916392116
   PubMed Web of Science ®Google Scholar
• CampbellGRZiabrevaIReeveAKMitochondrial DNA deletions and neurodegeneration in multiple sclerosisAnn Neurol201169348149221446022
   PubMed Web of Science ®Google Scholar
• HaiderLFischerMTFrischerJMOxidative damage in multiple sclerosis lesionsBrain2011134Pt 71914192421653539
   PubMed Web of Science ®Google Scholar
• TrappBDStysPKVirtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosisLancet Neurol20098328029119233038
   PubMed Web of Science ®Google Scholar
• MahadDJZiabrevaICampbellGMitochondrial changes within axons in multiple sclerosisBrain2009132Pt 51161117419293237
   PubMed Web of Science ®Google Scholar
• FergusonBMatyszakMKEsiriMMPerryVHAxonal damage in acute multiple sclerosis lesionsBrain1997120Pt 33933999126051
   PubMed Web of Science ®Google Scholar
• StokinGBLilloCFalzoneTLAxonopathy and transport deficits early in the pathogenesis of Alzheimer’s diseaseScience200530757131282128815731448
   PubMed Web of Science ®Google Scholar
• De VosKJGriersonAJAckerleySMillerCCRole of axonal transport in neurodegenerative diseasesAnnu Rev Neurosci20083115117318558852
   PubMed Web of Science ®Google Scholar
• Roll-MecakAValeRDStructural basis of microtubule severing by the hereditary spastic paraplegia protein spastinNature2008451717636336718202664
   PubMed Web of Science ®Google Scholar
• TrottaNOrsoGRossettoMGDagaABroadieKThe hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and functionCurr Biol200414131135114715242610
   PubMed Web of Science ®Google Scholar
• HazanJFonknechtenNMavelDSpastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegiaNat Genet199923329630310610178
   PubMed Web of Science ®Google Scholar
• LukongKEChangKWKhandjianEWRichardSRNA-binding proteins in human genetic diseaseTrends Genet200824841642518597886
   PubMed Web of Science ®Google Scholar
• OrrHTFTD and ALS: genetic ties that bindNeuron201172218919022017980
   PubMed Web of Science ®Google Scholar
• GaoFBTaylorJPRNA-binding proteins in neurological diseaseBrain Res201214621222682432
   PubMed Web of Science ®Google Scholar
• PolymenidouMLagier-TourenneCHuttKRBennettCFClevelandDWYeoGWMisregulated RNA processing in amyotrophic lateral sclerosisBrain Res2012146231522444279
   PubMed Web of Science ®Google Scholar
• LicatalosiDDDarnellRBSplicing regulation in neurologic diseaseNeuron20065219310117015229
   PubMed Web of Science ®Google Scholar
• DarnellRBPosnerJBParaneoplastic syndromes involving the nervous systemN Engl J Med2003349161543155414561798
   PubMed Web of Science ®Google Scholar
• OwensGPBennettJLLassmannHAntibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluidAnn Neurol200965663964919557869
   PubMed Web of Science ®Google Scholar
• LovatoLWillisSNRodigSJRelated B cell clones populate the meninges and parenchyma of patients with multiple sclerosisBrain2011134Pt 253454121216828
   PubMed Web of Science ®Google Scholar
• KeeganMPinedaAAMcClellandRLDarbyCHRodriguezMWeinshenkerBGPlasma exchange for severe attacks of CNS demyelination: predictors of responseNeurology200258114314611781423
   PubMed Web of Science ®Google Scholar
• KeeganMKonigFMcClellandRRelation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchangeLancet2005366948557958216099294
   PubMed Web of Science ®Google Scholar
• ElovaaraIKuusistoHWuXRintaSDastidarPReipertBIntravenous immunoglobulins are a therapeutic option in the treatment of multiple sclerosis relapseClin Neuropharmacol2011342848921301327
   PubMed Web of Science ®Google Scholar
• HaasJMaas-EnriquezMHartungHPIntravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis – results of a retrospective multicenter observational study over five yearsMult Scler200511556256716193894
   PubMed Web of Science ®Google Scholar
• HauserSLWaubantEArnoldDLB-cell depletion with rituximab in relapsing-remitting multiple sclerosisN Engl J Med2008358767668818272891
   PubMed Web of Science ®Google Scholar
• BosterAAnkenyDPRackeMKThe potential role of B cell-targeted therapies in multiple sclerosisDrugs201070182343235621142258
   PubMed Web of Science ®Google Scholar
• MeinlEDerfussTKrumbholzMProbstelAKHohlfeldRHumoral autoimmunity in multiple sclerosisJ Neurol Sci20103061–218018220817206
   PubMed Web of Science ®Google Scholar
• BrownDASawchenkoPETime course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitisJ Comp Neurol2007502223626017348011
   PubMed Web of Science ®Google Scholar
• DerfussTLiningtonCHohlfeldRMeinlEAxo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injuryJ Mol Med (Berl)201088875376120445955
   PubMed Web of Science ®Google Scholar
• MatheyEKDerfussTStorchMKNeurofascin as a novel target for autoantibody-mediated axonal injuryJ Exp Med2007204102363237217846150
   PubMed Web of Science ®Google Scholar
• RawesJACalabreseVPKhanOADeVriesGHAntibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseasesMult Scler1997363633699493635
   PubMed Web of Science ®Google Scholar
• NorgrenNEdelstamAStigbrandTCerebrospinal fluid levels of neurofilament light in chronic experimental autoimmune encephalomyelitisBrain Res Bull200567426426816182933
   PubMed Web of Science ®Google Scholar
• SadatipourBTGreerJMPenderMPIncreased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosisAnn Neurol19984469809839851447
   PubMed Web of Science ®Google Scholar
• SrivastavaRAslamMKalluriSRPotassium channel KIR4.1 as an immune target in multiple sclerosisN Engl J Med2012367211512322784115
   PubMed Web of Science ®Google Scholar
• CrossAHWaubantEAntibodies to potassium channels in multiple sclerosisN Engl J Med2012367217217422784120
   PubMed Web of Science ®Google Scholar
• LevinMKrichavskyMBerkJNeuronal molecular mimicry in immune mediated neurologic diseaseAnn Neurol199844187989667596
   PubMed Web of Science ®Google Scholar
• LeeSMDunnavantFDJangHZuntJLevinMCAutoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological diseaseNeurosci Lett20064011–218819316600502
   PubMed Web of Science ®Google Scholar
• LeeSShinYMarlerJLevinMCPost-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological diseaseJ Neuroimmunol20082041–214014818793806
   PubMed Web of Science ®Google Scholar
• LeeSShinYClarkDGotuzzoELevinMCCross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological diseaseJ Clin Immunol201232473674522392044
   PubMed Web of Science ®Google Scholar
• DreyfussGKimVNKataokaNMessenger-RNA-binding proteins and the messages they carryNat Rev Mol Cell Biol20023319520511994740
   PubMed Web of Science ®Google Scholar
• HanSPTangYHSmithRFunctional diversity of the hnRNPs: past, present and perspectivesBiochem J2010430337939220795951
   PubMed Web of Science ®Google Scholar
• LevinMCLeeSMMorcosYBradyJStuartJCross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicryJ Infect Dis2002186101514151712404172
   PubMed Web of Science ®Google Scholar
• KalumeFLeeSMMorcosYCallawayJCLevinMCMolecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firingJ Neurosci Res2004771828915197740
   PubMed Web of Science ®Google Scholar
• García-VallejoFDomínguezMCTamayoOAutoimmunity and molecular mimicry in tropical spastic paraparesis/human T-lymphotropic virus-associated myelopathyBraz J Med Biol Res200538224125015785836
   PubMed Web of Science ®Google Scholar
• SueokaEYukitakeMIwanagaKSueokaNAiharaTKurodaYAutoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patientsAnn Neurol200456677878615497154
   PubMed Web of Science ®Google Scholar
• YukitakeMSueokaESueoka-AraganeNSignificantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesisJ Neurovirol200814213013518444084
   PubMed Web of Science ®Google Scholar
• DouglasJGardnerLLeeSShinYGrooverCLevinMCAntibody transfection into neurons as a tool to study disease pathogenesisJournal of Visualized Experiments201267 pii 4154
   Google Scholar
• SchmuedLCStowersCCScalletACXuLFluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neuronsBrain Res200510351243115713273
   PubMed Web of Science ®Google Scholar
• StewartMMolecular mechanism of the nuclear protein import cycleNat Rev Mol Cell Biol20078319520817287812
   PubMed Web of Science ®Google Scholar
• ContiEMüllerCWStewartMKaryopherin flexibility in nucleocytoplasmic transportCurr Opin Struct Biol200616223724416567089
   PubMed Web of Science ®Google Scholar
• CookABonoFJinekMContiEStructural biology of nucleocytoplasmic transportAnnu Rev Biochem20077664767117506639
   PubMed Web of Science ®Google Scholar
• LeeBJCansizogluAESuelKELouisTHZhangZChookYMRules for nuclear localization sequence recognition by karyopherin beta 2Cell2006126354355816901787
   PubMed Web of Science ®Google Scholar
• HomayouniRHeinrichKWeiLBerryMWGene clustering by latent semantic indexing of MEDLINE abstractsBioinformatics200521110411515308538
   PubMed Web of Science ®Google Scholar
• MichaelWMChoiMDreyfussGA nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathwayCell19958334154228521471
   PubMed Web of Science ®Google Scholar
• HanzSPerlsonEWillisDAxoplasmic importins enable retrograde injury signaling in lesioned nerveNeuron20034061095110414687545
   PubMed Web of Science ®Google Scholar
• ThompsonKROtisKOChenDYZhaoYO’DellTJMartinKCSynapse to nucleus signaling during long-term synaptic plasticity; a role for the classical active nuclear import pathwayNeuron2004446997100915603742
   PubMed Web of Science ®Google Scholar
• YudinDHanzSYooSLocalized regulation of axonal RanGTPase controls retrograde injury signaling in peripheral nerveNeuron200859224125218667152
   PubMed Web of Science ®Google Scholar
• KimJYShenSDietzKHDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damageNat Neurosci201013218018920037577
   PubMed Web of Science ®Google Scholar
• MillerRHRenegade nuclear enzymes disrupt axonal integrityNat Neurosci201013214314420104203
   PubMed Web of Science ®Google Scholar
• BeetzCBrodhunMMoutzourisKIdentification of nuclear localisation sequences in spastin (SPG4) using a novel Tetra-GFP reporter systemBiochem Biophys Res Commun200431841079108415147984
   PubMed Web of Science ®Google Scholar
• RebaneAAabASteitzJATransportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuRRNA200410459059915037768
   PubMed Web of Science ®Google Scholar
• SalinasSCarazo-SalasREProukakisCSchiavoGWarnerTTSpastin and microtubules: functions in health and diseaseJ Neurosci Res200785122778278217348041
   PubMed Web of Science ®Google Scholar
• LazeronRHde SonnevilleLMScheltensPPolmanCHBarkhofFCognitive slowing in multiple sclerosis is strongly associated with brain volume reductionMult Scler200612676076817263004
   PubMed Web of Science ®Google Scholar
• LazeronRHBoringaJBSchoutenMBrain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosisMult Scler200511552453116193889
   PubMed Web of Science ®Google Scholar